As the world races to find a vaccine for COVID-19, our colleague Dr Cem Gun, an Emergency Medicine Physician at Acıbadem University Atakent Hospital, has bravely volunteered for the country’s first clinical trial. On 9 October, he was administered the first dose of a COVID-19 vaccine developed in China and approved for trial by the Health Institutes of Turkey, at a high-key milestone event.
On why he volunteered for this trial, Dr Cem Gun said, “As a healthcare worker, I fall into the high-risk group for COVID-19 infection. I decided to be vaccinated not only to protect myself but also my patients and loved ones. I made this decision with peace of mind as it is a controlled trial; it is currently in Phase 3, making it a tested and safe vaccine.”
The vaccine will be administered in two doses, and volunteers will be monitored on its effectiveness over a year.
The World Bank has approved US$12 billion in financing to help developing countries buy and distribute COVID-19 vaccines, tests and treatments, aiming to support the vaccination of up to 1 billion people.
Related Stories
Pantai Hospital Melaka Launches Malaysia's First Smart Fridge Hub for Oncology Medicines
Pantai Hospital Melaka, part of IHH Healthcare, has become the first hospital in Malaysia to launch a Smart Fridge micro-inventory hub for selected oncology medicines, marking a significant step forward in improving access to cancer treatment.
IHH Healthcare Marks Three Years of Partnership With Singapore Sea Regatta
Gleneagles Hospital Hong Kong Launches TeleCare SmartHub with SmarTone
IHH Healthcare Singapore and AIA Singapore Partner to Advance Value-based Care
IHH Singapore Advances the Conversation on Healthspan and Longevity
